Literature DB >> 10892765

Recovery from chronic hepatitis C in long-term responders to ribavirin plus interferon alfa.

H Fontaine, M L Chaix, J L Lagneau, C Bréchot, S Pol.   

Abstract

In 45 sustained responders to interferon alfa and ribavirin, we found long-lasting elimination of hepatitis C virus RNA from serum and liver, together with histopathological improvement, suggesting complete recovery from chronic hepatitis C.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10892765     DOI： 10.1016/S0140-6736(00)02434-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  3 in total

Review 1.  Grazoprevir/elbasvir combination therapy for HCV infection.

Authors:  Anaïs Vallet-Pichard; Stanislas Pol
Journal:  Therap Adv Gastroenterol       Date:  2016-10-17       Impact factor: 4.409

2.  Efficacy and tolerability of telaprevir for chronic hepatitis virus C genotype 1 infection: a meta-analysis.

Authors:  Yuan Kong; Xiaoping Wang; Yushu Shang; Paul M Schroder; Wenhua Liang; Xiaoting Ling; Zhiyong Guo; Xiaoshun He
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

Review 3.  Botanical immunodrugs: scope and opportunities.

Authors:  Bhushan Patwardhan; Manish Gautam
Journal:  Drug Discov Today       Date:  2005-04-01       Impact factor: 7.851
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.